DOF
Hwasong
About DOF
DOF specializes in regenerative medicine, including nerve conduit platforms. The company's products include allograft tissue and medical devices.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $12.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2023)
- Website: biodof.com
- Phone: +82-031-698-470
Industries & Categories
Biotechnology, Life Science, Media and Entertainment, Medical
Canonical: https://fsome.com/organization/dof-104010 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.